IO Combinations 360°

The 5th annual IO Combinations 360° is dedicated to fulfilling its mission to address clinical developments, scientific data and business aspects in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient's immune system to eradicate cancer.

IO Combinations 360° Delivers Three Key Benefits:

- Access to KOLs driving the science
- Partnership opportunities with all stakeholders in Immuno-Oncology and Combinations
- Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology Combinations

Key topics for 2020 include:

- Discovery / Preclinical Science
- Bispecifics
- Translational Science and Biomarkers
- Next Generation Cell Therapy
- Clinical Developments
- Operationalizing Combinations
- Business Aspects
- Emerging Technologies
 

Speakers: Najim Ajami, PhD, Mary Antonysamy, PhD, José Baselga, MD, PhD, Stephen Baylin, MD, Roy Baynes, MD, PhD, Sharon Benzeno, PhD, Daniel Chen, MD, PhD, Christina Coughlin, MD, PhD, Christina Derleth, MD, Alice Donnelly, Alex Franzusoff, PhD, Ronald Germain, MD, PhD, Asthika Goonewardene, MBA, James Gulley, MD, PhD, Omid Hamid, MD, Steve Hamilton, Jane Ann Healy, MD, PhD, Kristen Hege, MD, Genevive Hernandez, MD, Marc Hurlbert, PhD, Theresa LaVallee, PhD, Vanessa Lucey, PhD, Karen May, Mark O’Hara, MD, Geraldine O’Keeffe, Alessandra Polara, PhD, Saul Priceman, PhD, Raphaël F Rousseau, MD, PhD, Eytan Ruppin, MD, PhD, Michael Salgaller, PhD, Anjali Sharma, MD, Alexandra Snyder, MD, Patricia Soulard, MD, Edward Tenthoff, Scott Turner, PhD, Raluca Verona, PhD, Jim Wise, Luis Voloch, Dmitriy Zamarin MD, PhD, Frank Zenke, PhD

Others Details

Time: 09:30 to 15:30 Brochure: https://go.evvnt.com/669759-3?pid=6581